Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

FIDIA PHARMA USA INC. Introduces New Product Packaging for HYALO GYN® Featuring a Fresh, Feminine Look

Fidia Farmaceutici S.p.A.
Posted on: 28 Nov 16

Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronic acid (HA)-based products, and its wholly owned subsidiary, FIDIA PHARMA USA INC., introduces newly redesigned packaging for the vaginal hydrating gel, HYALO GYN®. While keeping its current formulation, HYALO GYN®’s new product packaging gives the innovative hydrating gel a dynamic and fresh, feminine look to help make it more appealing to those who may be suffering from vaginal dryness.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161128005900/en/

HYALO GYN introduces new packaging (Photo: Business Wire)

“Many women often suffer silently from the bothersome symptoms associated with vaginal dryness, but they do not have to. HYALO GYN®, with its unique hyaluronic acid derivative component Hydeal-D®, was made for women to provide long-lasting hydration,” said Aldo Donati, president, FIDIA PHARMA USA INC. “Women trust that HYALO GYN® can provide hydration in a non-hormonal vaginal hydrating gel without a messy buildup or unpleasant order. Keeping its same formulation, HYALO GYN® now features new packaging that exudes a fresher, more feminine look that we believe is more attractive and better aligns with the comfort, hydration and relief that HYALO GYN® provides to women.”

In a clinical trial among women who used HYALO GYN® for 30 days, nearly 80 percent reported feeling no messy sensation, and 100 percent of women reported reduction in unpleasant vaginal odor.1 It acts as a moisturizer and lubricant because of the strong hydrating properties of its hyaluronic acid derivative component, Hydeal-D®. Its unique properties allow it to adhere to the vaginal mucosa, enhancing the residence time, thus hydrating and protecting the tissue.

HYALO GYN® is a hormone-free, clear, odorless gel that supplements the body’s natural hydrating function and was developed specifically for women whose vaginal lining is not sufficiently hydrated.

The carbomer and propylene glycol, combined with the hyaluronic acid derivative, enable HYALO GYN® to achieve its thick, viscous gel form, and the mucoadhesive properties of the product allow it to adhere to the vaginal mucosa, enhancing the residence time, thus hydrating and protecting this tissue.2

HYALO GYN® can be ordered online in the U.S. For product information or to order, please call 1-855-844-0664 or visit www.hyalogyn.com.

About FIDIA PHARMA USA INC.

FIDIA PHARMA USA INC. is a wholly-owned subsidiary of Italian pharmaceutical manufacturer Fidia Farmaceutici S.p.A., an established leader in the hyaluronic acid market segment.

FIDIA PHARMA USA INC. is focused on expanding Fidia’s position in the U.S. and Canadian market, while upholding the company’s mission to provide consumers with innovative products that offer quality, safety and performance. FIDIA PHARMA USA INC. is headquartered in Parsippany, N.J. For more information, please visit www.fidiapharma.us.

About Fidia Farmaceutici S.p.A.

Fidia Farmaceutici S.p.A. is an Italian pharmaceutical company founded in 1946. It is a leader in research and marketing hyaluronic acid-based products, with several applications in the biomedical field, such as rheumatology, orthopaedics, surgery, wound care, tissue repair and dermo-aesthetics. Fidia Farmaceutici is part of the P&R Holding group. The company is located in Italy, with R&D facilities in Abano Terme (Padua) and Noto (Sicily). Fidia has more than 700 employees, and its revenue exceeds €250 million euros. Fidia Farmaceutici S.p.A.’s products are marketed in more than 100 countries, through wholly owned subsidiaries and a comprehensive network of international partnerships and distributors. Thanks to its investment in research, it has created a legacy of products with more than 600 patents to its name. For more information, please visit www.fidiapharma.com.

Indication

HYALO GYN® is a personal lubricant, for penile and/or vaginal application, intended to moisturize and lubricate, to enhance the ease and comfort of intimate sexual activity and supplement the body’s natural lubrication.

This product is compatible with condoms: lubricated/non-lubricated latex, lubricated polyurethane, lubricated natural skin.

1 Tempera, G. Evaluation of the tolerability and efficacy of Hyalgel Vaginal Gel for the treatment of vaginal dryness and irritation, 1998, data on file at Fidia Farmaceutici S.p.A.

2 Data on file at Fidia Farmaceutici S.p.A.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161128005900/en/

Business Wire
www.businesswire.com

Last updated on: 28/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.